-
Biden Pushes Vaccines, Masks as Best Defense Against Omicron Variant
Drugs
November 30, 2021
Vaccines and masks will be the United States' first line of defense against the new omicron variant, not lockdowns or border closures, President Joe Biden told the nation Monday.
-
Russia says Sputnik vaccine should work against Omicron, can produce boosters
FirstWordPharma
November 30, 2021
Russia on Monday said it would be ready to provide booster shots to protect against the Omicron coronavirus variant if needed, as reported in the National Post.
-
Enzychem and Cadila collaborate to produce Covid-19 vaccine in Korea
Pharmaceutical-Technology
November 30, 2021
Enzychem Lifesciences and Cadila Healthcare, a Zydus Group unit, have signed an agreement to manufacture the first-ever Covid-19 plasmid deoxyribonucleic acid (DNA) vaccine, ZyCoV-D.
-
India willing to supply Covishield, Covaxin: Mansukh Mandaviya to Latin American, Caribbean envoys
ExpressPharma
November 29, 2021
Interacting with ambassadors of Latin American and Caribbean nations, Union Health Minister Mansukh Mandaviya said India is willing to supply Covishield and Covaxin to these countries.
-
Could a Single Dose of the HPV Vaccine Be Enough?
Drugs
November 29, 2021
Women getting vaccinated against the cancer-causing human papillomavirus (HPV) now need two or three shots, but an African clinical trial suggests a single dose is just as effective.
-
EMA approves Pfizer-BioNTech COVID-19 vaccine for young children
PharmaTimes
November 29, 2021
The Food and Drug Administration (FDA) granted approval for emergency use of the Comirnaty vaccine in children in October 2021.
-
CHMP recommends use of Pfizer-BioNTech’s Covid-19 vaccine in children
Pharmaceutical-Business-Review
November 29, 2021
The Committee for Medicinal Products for Human Use (CHMP) of the European Medicines Agency (EMA) has recommended the use of Pfizer and BioNTech’s Covid-19 vaccine, Comirnaty, in children aged five to 11 years.
-
Clover Biopharmaceuticals begins Covid-19 vaccine booster trial
Pharmaceutical-Technology
November 29, 2021
Clover Biopharmaceuticals has begun a Phase II clinical trial to assess its Covid-19 vaccine candidate, SCB-2019 (CpG 1018/Alum), as a heterologous booster shot in people who received an initial vaccine regimen.
-
EMA recommends Pfizer-BioNTech’s Covid-19 vaccine for children
Pharmaceutical-Technology
November 29, 2021
The European Medicines Agency’s (EMA) Committee for Medicinal Products for Human Use (CHMP) has given a positive opinion on the use of Pfizer and BioNTech’s Covid-19 vaccine, Comirnaty, in children aged five to 12 years.
-
RDIF announces Sputnik V efficacy data from San Marino
ExpressPharma
November 26, 2021
The Russian Direct Investment Fund (RDIF) yesterday announced new positive real-world data of the Ministry of Health of the Republic of San Marino on efficacy of the Russian Sputnik V vaccine...